Certolizumab Prefilled Syringes and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Certolizumab Prefilled Syringes and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Prefilled Syringes-Insulin degludec
- Certolizumab Prefilled Syringes-Insulin Degludec (U-100) Prefilled Pens
- Certolizumab Prefilled Syringes-Insulin Degludec (U-100) Vials
- Certolizumab Prefilled Syringes-Insulin Degludec (U-200) Prefilled Pens
- Certolizumab Prefilled Syringes-Insulin degludec and liraglutide
- Certolizumab Prefilled Syringes-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Certolizumab Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Certolizumab Vials
- Insulin aspart, recombinant Subcutaneous-Cerubidine
- Insulin aspart, recombinant Subcutaneous-Cervarix
- Insulin aspart, recombinant Subcutaneous-Cervarix Intramuscular
- Insulin aspart, recombinant Subcutaneous-Cervidil